Searched for
MANKIND PHARMA SHARE PRICE
Bitcoin trades near $79,000 as Fed rate uncertainty, selling pressure weigh on crypto markets- Forget short-term pressure; in the long term, the right business is what pays: 5 mid-cap stocks with an upside potential of up to 36%
- Worried about long-term returns? No equity mutual fund lost money on 5- and 7-year SIPs
- D-Street in gloomy mood, but Kotak sees 3 triggers for rebounds and adds 5 midcap stocks to portfolioDalal Street faces significant market challenges, leading Kotak Institutional Equities to spotlight selective stock value. With large-cap s...27 Oct, 2026, 01.37 PM IST
- Mankind Pharma shares jump 8% as Q2 profit rises 38% to Rs 716 croreMankind Pharma shares jumped nearly 8% after the company reported a 38% year-on-year rise in Q2 profit to Rs 716 crore. Revenue grew 17%, s...27 Oct, 2026, 12.55 PM IST
- Mankind Pharma Q2 profit rises 38% to Rs 716 croreMankind Pharma has announced a profit increase of 37.7% to ₹716 crore during the September quarter. Revenue from operations rose to ₹4,337....27 Oct, 2026, 07.30 AM IST
- Sugar stocks: Short-term pain is real; has the long-term case broken? 7 stocks from the sugar-ethanol ecosystemThough this year's ethanol tender leaves sugar out, the long-term blending roadmap still points to rising ethanol use. The move is aimed at...26 Oct, 2026, 07.24 PM IST
- Mankind Pharma shares key business developments from Q2 & H1 of FY27The company outperformed the market by 1.1 times in both chronic and acute therapies. Cardiac and anti-diabetes brands registered growth of...26 Oct, 2026, 05.48 PM IST
- Weekly Top Picks: These stocks scored 10 on 10 on Stock Reports PlusStock Reports Plus, powered by Refinitiv, undertakes detailed company analysis for 4,000+ listed stocks. In addition to detailed company an...26 Oct, 2026, 04.00 PM IST
- Coforge slips 3% even as Jefferies, Nomura, others raise targets after Q2 earnings. Why are they bullish?Coforge shares fell despite strong Q2 results and brokerages raising target prices. Net profit surged 56.5% year-on-year to Rs 588.1 crore,...26 Oct, 2026, 09.57 AM IST
- Top Nifty50 stocks analysts suggest buying in this volatile weekStock Reports Plus, powered by Refinitiv, is a comprehensive report that evaluates five key components of 4,000+ listed stocks – earnings, ...26 Oct, 2026, 09.16 AM IST
- Two Trades for Today: A digital tech solutions company for a 5.4% rise, a top pharma stock for an almost 7% gainOur technical analysts identify select stocks every trading day that may gain momentum even in volatile markets. Here are the technical cal...25 Oct, 2026, 01.29 PM IST
- Tourism is the sector the market writes off in a downturn. Is it indicating something else? 7 stocks with upside potential of up to 27%For years the street has believed that when the economy slows, tourism and hotels are the first to feel it. The logic: A hotel stay is not ...24 Oct, 2026, 10.42 PM IST
- Swiggy shares crash 14%, hit 52-week low after Q2 results. Here’s why Jefferies, Nomura, Bernstein cut target priceSwiggy Share Price: Swiggy experienced a notable decline in share prices after announcing a Rs 922 crore loss for the quarter. Revenue from...23 Oct, 2026, 01.04 PM IST
- Two Trades for Today: A top pharma company for a 6.3% upmove, a large-cap hospitality stock for a gain of almost 7%Our technical analysts identify select stocks every trading day that may gain momentum even in volatile markets. Here are the technical cal...22 Oct, 2026, 11.47 PM IST
- Weekly Top Picks: These stocks scored 10 on 10 on Stock Reports PlusStock Reports Plus, powered by Refinitiv, undertakes detailed company analysis for 4,000+ listed stocks. In addition to detailed company an...22 Oct, 2026, 04.55 PM IST
- Every bad cycle ends the same way; problems find their own solutions: 5 large-cap stocks with upside potential of up to 27%What should you focus on when headwinds blow? Not the share price, and not the morning's news. It should be the business and the quality of...22 Oct, 2026, 04.46 PM IST
- Sun Pharma to raise Rs 10,000 crore to part-finance Organon dealSun Pharmaceutical Industries plans to raise ₹10,000 crore through two tranches of rupee-denominated bonds. The funds will help refinance b...21 Oct, 2026, 06.48 AM IST
- CPHI Milan: Beyond generics, how Indian pharma is rewriting its global playbookAt CPHI Milan, Indian pharma players are looking beyond traditional exports, using partnerships, licensing, CDMO, and differentiated produc...08 Oct, 2026, 04.29 PM IST
- When nothing is cheap, winners may come from any corner: 19 stocks with downside to upside potential of -28% to plus 22%Because each pharma company took a different road, they no longer rise and fall together. Where any one of them stands in 10 years depends ...07 Oct, 2026, 05.28 PM IST
Load More
